Position in AZN
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$26,082,420
-$656,075 QoQ
Shares Held
137,551
+1.5% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#23
of 567 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026TD Waterhouse Canada Inc. holds $797,907,309 across 17 Drug Manufacturers - General names. AZN ranks #7 (3.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
1,005,440 | $255,351,596 | |
| 2 | LLY |
ELI LILLY & Co
|
192,333 | $230,689,989 | |
| 3 | ABBV |
AbbVie Inc.
|
366,299 | $92,175,480 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
482,201 | $60,921,274 | |
| 5 | MRK |
Merck & Co., Inc.
|
354,395 | $45,539,757 | |
| 6 | AMGN |
Amgen Inc
|
103,282 | $37,400,477 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
137,551 | $26,082,420 | |
| 8 | PFE |
Pfizer Inc
|
673,108 | $16,208,440 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,082,420 | 137,551 | Shares | Defined | 2026-07-27 | |
| 2026-03-31 | $26,738,495 | 135,577 | Shares | Defined | 2026-05-12 | |
| No filing history on record for this holder in this stock. | ||||||